GlassScriptPhysician profile
Naveen Kumar Arora
NPI 1093006090
$2,262.14
in general payments reported to CMS, 2019-2025
23 companies · $300 in 2025
The $300 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $795 · 2020: $354 · 2021: $374 · 2022: $53.75 · 2023: $158 · 2024: $227 · 2025: $300.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $685.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $685.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $629.04 | 2019-2025 | Ams 700, Lithovue, Axonics |
| Neotract INC. | $370.25 | 2019-2020 | |
| Medtronic, INC. | $228.32 | 2021-2025 | Interstim |
| Astellas Pharma US INC | $186.84 | 2019-2021 | |
| Dendreon Pharmaceuticals LLC | $140.09 | 2019 | |
| Blue Earth Diagnostics | $87.63 | 2019-2021 | |
| Srs Medical Systems, INC. | $85.07 | 2019 | |
| Teleflex LLC | $70.15 | 2023 | Urolift |
| Convatec INC. | $69.15 | 2022-2023 | |
| Laborie Medical Technologies Corp. | $51.90 | 2024-2025 | Endosheath Technology |
| Abbvie INC. | $50.70 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $40.38 | 2023-2025 | Gemtesa |
| Procept Biorobotics Corporation | $38.96 | 2021 | |
| Axonics, INC. | $30.98 | 2024 | Axonics, Bulkamid |
| 180 Medical, INC. | $29.91 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $24.17 | 2025 | |
| Allergan, INC. | $21.44 | 2019 | |
| Progenics Pharmaceuticals, INC. | $21.43 | 2023 | Pylarify |
| Janssen Biotech, INC. | $20.20 | 2025 | Erleada |
| Travere Therapeutics, INC. | $18.91 | 2019-2021 | |
| Therapeuticsmd, INC. | $18.15 | 2019 | |
| Ferring Pharmaceuticals INC. | $14.71 | 2025 | Adstiladrin |
| Coloplast Corp | $13.76 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Naveen Arora listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.